[
  {
    "ts": null,
    "headline": "Hyundai to invest $20B in US manufacturing",
    "summary": "Korean automaker Hyundai is the latest to announce plans to boost investment in the U.S. to ramp up domestic manufacturing. It is the latest in a growing number of companies to do so.",
    "url": "https://finnhub.io/api/news?id=cc7246aeb83bbd9355a55210386a4e8fe024f3e91e4f3c1ce27decc92c7dc27d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742837118,
      "headline": "Hyundai to invest $20B in US manufacturing",
      "id": 133360341,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Korean automaker Hyundai is the latest to announce plans to boost investment in the U.S. to ramp up domestic manufacturing. It is the latest in a growing number of companies to do so.",
      "url": "https://finnhub.io/api/news?id=cc7246aeb83bbd9355a55210386a4e8fe024f3e91e4f3c1ce27decc92c7dc27d"
    }
  },
  {
    "ts": null,
    "headline": "Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped",
    "summary": "There's a price war brewing in GLP-1 weight loss drugs, and now it's going global.",
    "url": "https://finnhub.io/api/news?id=b5168e51ac24f355e66c44f30c39311e3f3f3099e72b2b3beceb901e8f731f99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742834641,
      "headline": "Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped",
      "id": 133349434,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "There's a price war brewing in GLP-1 weight loss drugs, and now it's going global.",
      "url": "https://finnhub.io/api/news?id=b5168e51ac24f355e66c44f30c39311e3f3f3099e72b2b3beceb901e8f731f99"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
    "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=9007f6074e96b305f4d0f2d001e77b86ffa1257ae727cca9154b81688b01d65e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742833860,
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "id": 133361138,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=9007f6074e96b305f4d0f2d001e77b86ffa1257ae727cca9154b81688b01d65e"
    }
  },
  {
    "ts": null,
    "headline": "Was Jim Cramer Right About Eli Lilly and Company (LLY)?",
    "summary": "We recently published a list of Was Jim Cramer Right About These 23 Stocks? In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discussed 12 months ago. In the most recent Mad Money episode, Jim Cramer shared his thoughts on [因",
    "url": "https://finnhub.io/api/news?id=38dfe7662a89a34b2b9f85ba9762875c3bf2151f499c24c6a95c47cc2dd589dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742831940,
      "headline": "Was Jim Cramer Right About Eli Lilly and Company (LLY)?",
      "id": 133349435,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of Was Jim Cramer Right About These 23 Stocks? In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discussed 12 months ago. In the most recent Mad Money episode, Jim Cramer shared his thoughts on [因",
      "url": "https://finnhub.io/api/news?id=38dfe7662a89a34b2b9f85ba9762875c3bf2151f499c24c6a95c47cc2dd589dd"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Advantage Large Cap Core Fund Q4 2024 Commentary",
    "summary": "BlackRock Advantage Large Cap Core Fund posted returns of 1.92% (Institutional shares) and 1.86% (Investor A shares, without sales charge) for the fourth quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=430929fbccc3e0cec9a25544bbf5b4d48193658388fa1e9accf17d6312ff57bc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742828760,
      "headline": "BlackRock Advantage Large Cap Core Fund Q4 2024 Commentary",
      "id": 133356623,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1479375885/image_1479375885.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "BlackRock Advantage Large Cap Core Fund posted returns of 1.92% (Institutional shares) and 1.86% (Investor A shares, without sales charge) for the fourth quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=430929fbccc3e0cec9a25544bbf5b4d48193658388fa1e9accf17d6312ff57bc"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Could See Higher Q1 Sales for Zepbound, UBS Says",
    "summary": "Eli Lilly and Company (LLY) could see higher sales for its Zepbound weight loss drug for Q1 after mi",
    "url": "https://finnhub.io/api/news?id=95f0f8beacece915dc0fbef14855443af701997baea8f77b1ff4c31ed2c12c4c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742827290,
      "headline": "Eli Lilly Could See Higher Q1 Sales for Zepbound, UBS Says",
      "id": 133349436,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Company (LLY) could see higher sales for its Zepbound weight loss drug for Q1 after mi",
      "url": "https://finnhub.io/api/news?id=95f0f8beacece915dc0fbef14855443af701997baea8f77b1ff4c31ed2c12c4c"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble.",
    "summary": "Novo Nordisk stock dropped Monday after the drugmaker licensed a Chinese competitor's weight-loss drug for $200 million up front.",
    "url": "https://finnhub.io/api/news?id=036e803d08ce76480c7fa26b6419a72598dd533b8b21e370aad98e9cbee46901",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742823271,
      "headline": "Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble.",
      "id": 133337769,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Novo Nordisk stock dropped Monday after the drugmaker licensed a Chinese competitor's weight-loss drug for $200 million up front.",
      "url": "https://finnhub.io/api/news?id=036e803d08ce76480c7fa26b6419a72598dd533b8b21e370aad98e9cbee46901"
    }
  },
  {
    "ts": null,
    "headline": "Is Eli Lilly and Company (LLY) The Best Healthcare Dividend Stock to Invest in?",
    "summary": "We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best healthcare dividend stocks to invest in. The US healthcare sector has been at the forefront since the emergence of COVID-19 [因",
    "url": "https://finnhub.io/api/news?id=599eb74e9d9500792ec30342a2649d4890f2e60698ad246e5683ec7f4a028c99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742822137,
      "headline": "Is Eli Lilly and Company (LLY) The Best Healthcare Dividend Stock to Invest in?",
      "id": 133337770,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best healthcare dividend stocks to invest in. The US healthcare sector has been at the forefront since the emergence of COVID-19 [因",
      "url": "https://finnhub.io/api/news?id=599eb74e9d9500792ec30342a2649d4890f2e60698ad246e5683ec7f4a028c99"
    }
  },
  {
    "ts": null,
    "headline": "Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains",
    "summary": "Five AI-powered stocks have strong revenues and earnings growth potentials for 2025. These are: MDT, LLY, BSX, NVS, ABT.",
    "url": "https://finnhub.io/api/news?id=9f607916861a251ac2f38010bc94af9ad6339bdd02a60b1848572732d128835f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742820300,
      "headline": "Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains",
      "id": 133337771,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Five AI-powered stocks have strong revenues and earnings growth potentials for 2025. These are: MDT, LLY, BSX, NVS, ABT.",
      "url": "https://finnhub.io/api/news?id=9f607916861a251ac2f38010bc94af9ad6339bdd02a60b1848572732d128835f"
    }
  },
  {
    "ts": null,
    "headline": "Novo adds to obesity drug pipeline via $200M deal with China-based biotech",
    "summary": "The licensing pact adds a second so-called \"triple agonist\" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.",
    "url": "https://finnhub.io/api/news?id=d6d04a052ada8ae407b72f5307ea4face56ac41fcbd94c45bfe5c9026c61821b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742817720,
      "headline": "Novo adds to obesity drug pipeline via $200M deal with China-based biotech",
      "id": 133349437,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The licensing pact adds a second so-called \"triple agonist\" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.",
      "url": "https://finnhub.io/api/news?id=d6d04a052ada8ae407b72f5307ea4face56ac41fcbd94c45bfe5c9026c61821b"
    }
  },
  {
    "ts": null,
    "headline": "Market Sell-Off: Can Buying These 3 \"Safe\" Stocks Today Set You Up for Life?",
    "summary": "These fundamentally strong stocks remain safer picks, despite the heightened market volatility.",
    "url": "https://finnhub.io/api/news?id=6686356cd6b3a68cc8486ef748b4a53ddd7b2f15a74395653727df2f27760d80",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742817600,
      "headline": "Market Sell-Off: Can Buying These 3 \"Safe\" Stocks Today Set You Up for Life?",
      "id": 133337749,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "These fundamentally strong stocks remain safer picks, despite the heightened market volatility.",
      "url": "https://finnhub.io/api/news?id=6686356cd6b3a68cc8486ef748b4a53ddd7b2f15a74395653727df2f27760d80"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Capital Appreciation V.I. Fund Q4 2024 Commentary",
    "summary": "BlackRock Capital Appreciation V.I. Fund Q4 2024 Commentary",
    "url": "https://finnhub.io/api/news?id=9a6a407a1ebed5de348354fb85c4398dbf13c8068df2b4daac1ad808839c6581",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742813940,
      "headline": "BlackRock Capital Appreciation V.I. Fund Q4 2024 Commentary",
      "id": 133340811,
      "image": "",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=9a6a407a1ebed5de348354fb85c4398dbf13c8068df2b4daac1ad808839c6581"
    }
  },
  {
    "ts": null,
    "headline": "J&J to Invest $55B in United States to Boost Manufacturing, R&D",
    "summary": "JNJ announces plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States.",
    "url": "https://finnhub.io/api/news?id=53ab7bfa3ac32d36cb0505e7e10c4504bd1893625fb2310561392cd335b3d434",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742812140,
      "headline": "J&J to Invest $55B in United States to Boost Manufacturing, R&D",
      "id": 133337773,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "JNJ announces plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States.",
      "url": "https://finnhub.io/api/news?id=53ab7bfa3ac32d36cb0505e7e10c4504bd1893625fb2310561392cd335b3d434"
    }
  },
  {
    "ts": null,
    "headline": "Lilly, Novo expand DTC reach of obesity meds after compound win",
    "summary": "The FDA delisted semaglutide and tirzepatide from its shortage list, putting an end to copycat GLP-1s.",
    "url": "https://finnhub.io/api/news?id=a6470d94174416a3f251457fbbfc177382a83b9d3d3866107ff14809970a019c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742803200,
      "headline": "Lilly, Novo expand DTC reach of obesity meds after compound win",
      "id": 133337774,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The FDA delisted semaglutide and tirzepatide from its shortage list, putting an end to copycat GLP-1s.",
      "url": "https://finnhub.io/api/news?id=a6470d94174416a3f251457fbbfc177382a83b9d3d3866107ff14809970a019c"
    }
  }
]